Evidence map›Paper›PMID 38155969›Full record

ArticleFrontiers in immunology2023

Complement C1q and von Willebrand factor interaction in atherosclerosis of human carotid artery.

Kristina Schulz, Claudia Donat, Mukesh Punjabi, Katharina Glatz, Beat Kaufmann, Marten Trendelenburg

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Diagnostic and Prognostic Value of C1q in Sepsis-Induced Coagulopathy.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kristina Schulz *Laboratory of Clinical Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.
Claudia Donat *Laboratory of Clinical Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.
Mukesh PunjabiLaboratory of Cardiovascular Molecular Imaging, Department of Biomedicine, University of Basel, Basel, Switzerland.
Katharina GlatzInstitute for Pathology, University Hospital of Basel, Basel, Switzerland.
Beat KaufmannDivision of Cardiology, University Hospital of Basel, Basel, Switzerland.
Marten TrendelenburgLaboratory of Clinical Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.
University Hospital of Basel · CHUniversity of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atherosclerosis is an inflammatory disease of the vessel wall, with cholesterol crystal (CC) deposition being a hallmark of the disease. As evidence for a cross-talk between complement activation and hemostasis on CC surfaces has been limited to

Indexed as

AtherosclerosisPlaque, AtheroscleroticCarotid ArteriesComplement C1qHumansvon Willebrand FactorComplement C1qvon Willebrand FactoratherosclerosisC1qcomplementhemostasisvon Willebrand factorvWF

Identifiers

PMID38155969
PMCPMC10753016
OpenAlexW4389729080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.